MedTrace Logo

Real-world Clinical Efficacy of Abatacept in the T3 Data Registry

NCT01555879 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-11-06

No results posted yet for this study

Summary

The purpose of this study is to assess the effectiveness of Abatacept in real-world clinical practice. The main hypothesis to be examined in this study is, "Abatacept's effectiveness results in a single real-world clinic (n = 100) are reproducible at another site (n \~= 200)".

Conditions

  • Arthritis, Rheumatoid

Interventions

DRUG

Abatacept

As prescribed by a doctor for patient medical care.

Sponsors & Collaborators

Principal Investigators

  • Keith Knapp, Ph.D. · Arthritis Northwest PLLC

  • Gary Craig, M.D. · Arthritis Northwest PLLC

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01555879 on ClinicalTrials.gov